The startup nabbed a $29.3 billion valuation in a $2.3 billion funding round Thursday, minting its four 20-something founders as billionaires.
Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...